Regulatory Landscape for Probiotics in Key Global Markets

Probiotic regulation varies dramatically by jurisdiction—what qualifies as a food supplement in one country may require a drug registration in another. Brands planning global distribution must understand these frameworks before committing to formulation and labelling decisions.

United States (US FDA / FTC)

Probiotics are regulated as dietary supplements under DSHEA 1994 (21 CFR Part 111). There is no pre-market approval requirement, but strict GMP compliance is mandatory. Structure/function claims are permitted with a disclaimer ('This statement has not been evaluated by the FDA…') but health claims linking to disease prevention require authorisation. The FTC governs advertising and requires substantiation for any efficacy claim.

• No pre-market registration required for dietary supplements
• GMP compliance under 21 CFR Part 111 mandatory
• Label must carry Supplement Facts panel with Dietary Supplement declaration
• 75-day notification required for structure/function claims
• FDA facility registration mandatory for US importers

European Union (EFSA / EC)

The EU applies a strict health claims regulation (EC 1924/2006). No probiotic health claims have been approved by EFSA to date—the term 'probiotic' itself cannot appear in labelling for products marketed in many EU member states. Products are sold as food supplements under Directive 2002/46/EC. Germany, France and Nordic countries have additional national restrictions.

The EU represents the world's most stringent probiotic labelling environment. Brands must work closely with regulatory counsel per market—what is permitted in Poland may not be in France. — ELMED Compliance Team

India (FSSAI)

FSSAI regulates probiotics under the Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations 2022. Probiotic strains must be from the approved list (Schedule I), and minimum viable count at end of shelf life must be declared.

• Only strains listed in FSSAI Schedule I are permitted
• Minimum CFU count at EOS must appear on label
• Product registration required for nutraceutical claims
• FSSAI licence mandatory for manufacturer and importer

ASEAN Markets

ASEAN has no harmonised probiotic framework. Each country applies its own food supplement or traditional medicine regulations. Singapore (HSA), Malaysia (BPFK), Thailand (FDA-TH), and Indonesia (BPOM) all operate separate registration systems with different approval timelines (ranging from 3 months in Singapore to 18+ months in Indonesia).

Practical Guidance for Multi-Market Launches

• Choose strains with GRAS/QPS status to maximise global regulatory acceptance
• Design labels with claim-neutral language that can be adapted per market
• Obtain a Free Sale Certificate (FSC) from your manufacturing country—required by most importers
• Maintain complete technical dossiers: COA, stability data, strain identity, manufacturing site info
• Engage local regulatory consultants in primary target markets before artwork is finalised